Assignee's Change of Address

Recorded: 2025-11-20 Pages: 2

Assignor

CHEMOCENTRYX, INC.

Executed: 2023-06-23

Assignee

CHEMOCENTRYX, INC.

ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CALIFORNIA, 91320-1799

Covered Property (1)

Combination Therapy Using a Chemokine Receptor 2 (CCR2) Antagonist and a Pd-1/Pd-L1 Inhibitor

Application: 18/411,245 →

Publication: US 2024/0285593

Related Assignments (1)

Other recorded transfers of the patent in this record — the chain of ownership.